Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 5 studies | 32% ± 14% | |
| cardiac muscle cell | 4 studies | 27% ± 5% | |
| Mueller cell | 4 studies | 48% ± 23% | |
| GABAergic neuron | 3 studies | 26% ± 5% | |
| glutamatergic neuron | 3 studies | 38% ± 15% | |
| endothelial cell of lymphatic vessel | 3 studies | 27% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 32% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 10426.55 | 653 / 653 | 87% | 46.33 | 525 / 605 |
| kidney | 99% | 483.99 | 88 / 89 | 85% | 132.72 | 767 / 901 |
| prostate | 100% | 1130.33 | 245 / 245 | 22% | 1.90 | 108 / 502 |
| brain | 79% | 373.70 | 2088 / 2642 | 32% | 5.34 | 229 / 705 |
| lung | 94% | 308.11 | 543 / 578 | 10% | 1.36 | 111 / 1155 |
| heart | 98% | 1090.15 | 841 / 861 | 0% | 0 | 0 / 0 |
| spleen | 92% | 243.26 | 221 / 241 | 0% | 0 | 0 / 0 |
| intestine | 84% | 344.21 | 812 / 966 | 1% | 0.21 | 7 / 527 |
| breast | 79% | 314.83 | 363 / 459 | 5% | 0.60 | 55 / 1118 |
| esophagus | 77% | 219.86 | 1118 / 1445 | 5% | 1.70 | 10 / 183 |
| stomach | 76% | 270.45 | 273 / 359 | 3% | 0.26 | 10 / 286 |
| ovary | 6% | 11.81 | 11 / 180 | 72% | 16.98 | 309 / 430 |
| uterus | 56% | 186.24 | 95 / 170 | 22% | 7.95 | 101 / 459 |
| skin | 72% | 626.50 | 1310 / 1809 | 4% | 0.38 | 17 / 472 |
| adipose | 54% | 111.05 | 646 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 47% | 102.54 | 120 / 258 | 3% | 0.83 | 8 / 230 |
| muscle | 50% | 130.73 | 400 / 803 | 0% | 0 | 0 / 0 |
| liver | 29% | 52.88 | 65 / 226 | 3% | 0.38 | 14 / 406 |
| blood vessel | 30% | 59.15 | 395 / 1335 | 0% | 0 | 0 / 0 |
| bladder | 19% | 40.05 | 4 / 21 | 4% | 0.87 | 22 / 504 |
| eye | 0% | 0 | 0 / 0 | 23% | 2.70 | 18 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 22% | 7.33 | 10 / 45 |
| peripheral blood | 9% | 16.33 | 84 / 929 | 0% | 0 | 0 / 0 |
| pancreas | 1% | 2.84 | 2 / 328 | 6% | 0.37 | 10 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.18 | 1 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0005604 | Cellular component | basement membrane |
| GO_0005615 | Cellular component | extracellular space |
| GO_0009986 | Cellular component | cell surface |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005581 | Cellular component | collagen trimer |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0008201 | Molecular function | heparin binding |
| GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | COL23A1 |
| Protein name | Collagen type XXIII alpha 1 chain Alternative protein COL23A1 (Collagen type XXIII alpha 1 chain) Collagen alpha-1(XXIII) chain |
| Synonyms | |
| Description | |
| Accessions | A0A7P0T8B8 ENST00000390654.8 [Q86Y22-1] ENST00000680268.1 A0A2R8Y887 ENST00000680889.1 ENST00000681261.1 A0A0A0MSD3 L8EAS4 ENST00000679896.1 Q86Y22 ENST00000646779.1 ENST00000407622.3 |